- Kristi Powers
Choose the health content that’s right for you, and get it delivered right in your inbox.

A new genetic test for patients with colorectal cancer, being studied at AdventHealth, can detect if a patient has cancer from a simple blood draw. The groundbreaking test could allow patients to avoid chemotherapy after having surgery to remove a tumor. The test searches for circulating tumor DNA (ctDNA), which is a sequencing technology that can detect very small amounts of tumor DNA in the body’s circulatory system.
“What we knew is that a lot of those patients were cured with surgery alone. We just didn’t have a way to know which ones had microscopic cancer left in the blood, who needed chemo and who did not,” said Dr. Mohamedtaki Tejani, medical oncologist and director of the Gastrointestinal Oncology program at the AdventHealth Cancer Institute and the AdventHealth Research Institute, told the Orlando Sentinel.
Colorectal cancer is the fourth most common cancer diagnosed in the U.S. and the second leading cause of cancer-related deaths. Dr. Tejani is leading the AdventHealth site with two National Cancer Institute clinical trials that aim to harness this sequencing technology to improve patient care. The trial related to Stage 3 colon cancer and the BESPOKE study are currently enrolling participants through a referral process with the AdventHealth Gastrointestinal Oncology Program. Click the link for each study for more information on how to enroll.
In the future, Dr. Tejani hopes this genetic test, which has to be ordered by a physician, can also be used to prescreen for very early-stage colon cancer, and also more effectively treat other cancers, such as gynecologic or pancreatic cancers.
Read the full Orlando Sentinel story here.
Recent News
AdventHealth Minneola CEO Kay Barnett, featured on The Crossman Conversation podcast.
AdventHealth is thrilled to have Laura M. Sullivan, MSN, APRN, NNP-BC, as part of our care team at The Baby Place at AdventHealth Hendersonville.
AdventHealth’s annual sports physicals event for Flagler Schools will be May 21 and 22 from 5 to 9 p.m. at Flagler Palm Coast High School, 5500 East Highway 100, Palm Coast.
An innovative effort is underway to increase the number of organ donors in minority communities.
April is recognized as IBS Awareness Month, dedicated to educating the public about irritable bowel syndrome (IBS), its symptoms, and the importance of seeking appropriate treatment.
Expected to open by 2026, the AdventHealth Training Center at Jackie Robinson Ballpark will enhance player wellness and support downtown revitalization.
– AdventHealth Manchester is proud to announce the success of our recent Coffee & Conversation event held on National Health Care Decision Day. The event took place at the AdventHealth Primary Care...
AdventHealth and Orange County collaborate to enhance mortality and neurological outcomes at AdventHealth Orlando.
Nicol McGough understands all too well how physical inactivity brought on by illness or injury can severely damage a person’s well-being.
AdventHealth Primary Care Clinic is thrilled to announce the addition of Jessica Napier, PA-C, to our Women's Care Team. Jessica will be joining Dr. Shawn Gorden in providing comprehensive women's...
AdventHealth Heart of Florida and AdventHealth Lake Wales earn prestigious national recognition for promoting organ, eye and tissue donation
AdventHealth Wesley Chapel is proud to announce its groundbreaking achievement as the first hospital in Pasco County to perform a new, minimally invasive renal denervation (RDN) procedure.